Portfolio company
Moximed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops implantable shock absorbers for patients with knee osteoarthritis to reduce joint load and delay the need for replacement surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
Miach Orthopaedics
This company develops bio-engineered surgical implants to facilitate natural healing of torn anterior cruciate ligaments for patients with knee injuries.
Orthosensor
This company develops sensor-assisted surgical devices and data platforms for orthopaedic surgeons and hospitals to improve knee replacement outcomes.
Moroxite F
This company develops regenerative medicine solutions to improve implant anchorage in osteoporotic bone for patients undergoing orthopaedic surgery.
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
Peptilogics
This company develops engineered peptide therapeutics to treat and prevent medical device-related infections for patients undergoing joint replacements.
Emovi
This company develops AI-powered medical devices that measure 3D dynamic knee alignment to assist orthopaedic providers and surgeons with patient diagnosis and treatment.
